OAC
AUPH icon

OMERS Administration Corp’s Aurinia Pharmaceuticals AUPH Stock Holding History

OMERS Administration Corp’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
+90,400
New +$1.32M 0.01% 598
2025
Q4 		– Sell
-20,800
Closed -$230K – 1070
2025
Q3 		$230K Buy
+20,800
New +$227K ﹤0.01% 946

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OMERS Administration Corp's AUPH Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 90,400 shares worth $1.34M. The stake represents 0.01% of the portfolio and ranks #598 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in AUPH as recently as Q3 2025.

OMERS Administration Corp first reported a position in AUPH in Q3 2025 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • OMERS Administration Corp held 90,400 shares of Aurinia Pharmaceuticals worth $1.34M as of Q1 2026.
  • Aurinia Pharmaceuticals was a new OMERS Administration Corp position in Q1 2026.
  • Aurinia Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #598 holding.
  • OMERS Administration Corp first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.